Диссертация (Разработка лекарственных форм нифедипина с применением твердых дисперсий), страница 17
Описание файла
Файл "Диссертация" внутри архива находится в папке "Разработка лекарственных форм нифедипина с применением твердых дисперсий". PDF-файл из архива "Разработка лекарственных форм нифедипина с применением твердых дисперсий", который расположен в категории "". Всё это находится в предмете "фармацевтика" из Аспирантура и докторантура, которые можно найти в файловом архиве МГМУ им. Сеченова. Не смотря на прямую связь этого архива с МГМУ им. Сеченова, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата фармацевтических наук.
Просмотр PDF-файла онлайн
Текст 17 страницы из PDF
70 – 73.123. Шорманов В.К. Определение нифедипина в биологическом материале /В.К. Шорманов, Л.Л. Квачахия, М.Ю. Маркелов, Е.Г. Конарева //Судебно-медицинская экспертиза. – 2011. – № 4. – С. 31 – 34.124. Abcarian H., Lakshmanan S., Read D.R. The role of internal sphincter inchronic anal fissures. Dis. Colon Rectum. – 1982. – Vol.25. – P. 525 – 528.126125. Ahire B.R.
Solubility enhancement of poorly water-soluble drug by soliddispersion techniques // Int. J. PharmTech Res. – 2010. – Vol. 2. – № 3. P. 2007– 2015.126. Almeida H., Amaral M. H., Lobao P., Sousa Lobo J.M. Pluronic F- 127 andPluronic Lecithin Organogel (PLO): Main Features and their Applications inTopical and Transdermal Administration of Drugs // J Pharm Pharmaceut. –2012. – Sci.l5(4). – P. 592 – 605.127. Bacher H., Mischinger Hi., Werkgartner G., et al. Local nitroglycerin fortreatment of anal fissures: an alternative to lateral sphincterotomy Dis ColonRectum. – 1997.
– P. 840 – 845.128. Bikiaris D. Physicochemical studies on solid dispersions of poorly watersoluble drugs // Thermochim. Acta. – 2005. – Т. 439. – № 1 – 2. – P. 58 – 67.129. Boghra R.J. Solubility, dissolution rate and bioavailability enhancement ofirbesartan by solid dispersion technique // Chem.
Pharm. Bull. (Tokyo). – 2011.– Vol. 59. – № 4. – P. 438 – 441.130. Bolourchian N., Mehdi Mahboobian M., Dadachzadeh S. The Effect of PEGMolecular Weights on Dissolution Behavior of Simvastatin in Solid Dispertions// Iran. farm. res. journ. – 2013. – 12 suppl. – P. 11 – 20.131. Chung Chow S.
Bioavailability and Bioequivalence in Drug Development //Wiley Interdisciplinary Reviews Computational Statistics (WIREs Comp Stats).– 2014. –№ 6 (4). – Р. 304 – 312.132. Cook T.A., Brading A.F., Mortensen N.J. Differences in contractileproperties of anorectal smooth muscle and the effects of calcium channelblockade // Br J Surg.
–1999. – № 86 (l) 70 – 5. – P. 34 – 39.133. Collins E.E., Lund J. N. A review of chronic anal fissure management //Tech Coloproctol. – 2007. – Vol. 11, № 3. – P. 209 – 23.134. Craig D.Q. The mechanism of drug release from solid dispersions in watersoluble polymers // Int. J. Pharm. – 2002. – Vol. 231. – № 2. – P.
131 – 140.127135. Dalton J.T., Yates C.R. Bioavaliability of drugs and bioequivalence // Enc.of pharm. tech. – 2007. – P. 164 – 167.136. Dahiya S. Studies on formulation development of a poorly water-solubledrug Abstract // Thai. J. Pharm. Sci. – 2010. – Vol. 34. – P. 77 – 87.137. Das S.K. Solid Dispersions: An Approach to Enhance the Bioavailability ofPoorly Water-Soluble Drugs // Int. J.
Pharmacol. Pharm. Technol. – 1960. – №1. – P. 33 – 46.138. Das S.K. Enhancing the Bioavailability of Poorly Water-Soluble Drugs //Int. J. Pharmacol. Pharm. Technol. – 2011. – № 1. – P. 37 – 46.139. Defeyter PJ, Kerkkamph HJ, DeJong JP et al. Sustained beneficial effect ofnifedipine in primary pulmonary hypertension // Am Heart J. – 1983. – № 105.– P. 333 – 334.140. Dhawan S., Chopra S. Nonsurgical Approaches for the Treatment of AnalFissures // The American Journal of Gastroenterology.
– 2007. – № 102. – P.1312 – 1320.141. Dhirendra K. Solid dispersions: A review // Pak. J. Pharm. Sci. – 2009. –Vol. 22. – № 2. – P. 234 – 246.142. Drooge D. V. Chapter 1 Introduction: Production, stability and dissolution ofsolid dispersions to improve the bioavailability of class II lipophilic drugs. –2006. – P. 6 – 42.143. Epstein M.
Calcium antagonists and renal protection: current status andfuture prospective // Arch Intern Med. – 1992. – № 152. – P. 1573 – 1584.144. European Pharmacopoeia 8.0 ed. 2014. – 3162 р.145. Farid M., El Nakeeb A., Youssef M. et al. Idiopathic hypertensive analcanal: a place of internal sphincterotomy // J Gastrointest Surg. – 2009. – P. 58– 63.146. Fujimoto Y., Hirai N., Takatani-Nakase T., Takahashi K.
Preparation andEvaluation of Solid Dispersion Tablets by a Simple and Manufacturable Wet128Granulation Method Using Porous Calcium Silicate // ChemPharmBull(Tokyo). – 2016. – № 64(4). – P. 15 – 19.147. Gauri N. Solubility enhancement of a poorly aqueous soluble drugketoprofen using solid dispersion technique // Der Pharm. Sin. – 2011.
– Vol. 2.– № 4. – P. 67 – 73.148. Gorfme S.R. Treatment of benign anal disease with topical nitroglycerin. DisColon Rectum 1995;38:453-7.9.149. Grosskopf I., Shaish A., Charach G. et al. Nifedipine Treatment forHypertension is Associated with Enhanced Lipolytic Activity and AcceleratedClearance of Postprandial Lipemia // HormMetabRes.
– 2016. – №48(4):25762. – P. 26 – 31.150. Gurunath S. Amorphous solid dispersion method for improving oralbioavailability of poorly water-soluble drugs // J. Pharm. Res. – 2013. – Vol. 6.– № 4. – P. 476 – 480.151. Haque A. Studies to Improve Dissolution Properties of Poorly SolubleCarbamazipine by Solid Dispersion // Bangladesh Pharm.
J. – 2012. – Vol. 15.– № 1. – P. 73 – 77.152. Henning T. Polyethylene glycols (PEGs) and the pharmaceutical industry //Fine. Spec. Perform. Chem. – 2002. – № 6. – P. 57 – 59.153. Huang, Y. Fundamental aspects of solid dispersion technology for poorlysoluble drugs // Acta Pharm. Sin. B. – 2014. – Vol. 4. – № 1. – P. 18 – 25.154. Joshi H.N. Bioavailability enhancement of a poorly water-soluble drug bysolid dispersion in polyethylene glycol-polysorbate 80 mixture // Int. J.
Pharm.– 2004. – Vol. 269. – № 1. – P. 251 – 258.155. Katoh N., Hirano S., Kishimoto S., Yasuno H. Calcium channel blockerssuppress the contact hypersensitivity reaction (CHR) by inhibiting antigentransport and presentation by epidermal Langerhans cells in mice // Clin ExpImmunol. – 1997. – №108. – P. – 302 – 308.129156. Katsinelos P., Kountouras J., Paroutoglou G. et al. Aggressive treatment ofacute anal fissure with 0.5% nifedipine ointment prevents its evolution tochronicity // World J Gastroenterol. – 2006. – № 12 (38).
– P. 6203 – 6206.157. Khan G.M., Jiabi Z. Preparation, characterization, and dissolution studies ofibuprofen solid dispersions using polyethylene glycol (PEG), talc, and glycolPEG-talc as solid dispertion carriers // Drug Dev. Ind. Pharm. – 1998. – Vol.24. – №5. – P. 455 – 462.158. Kirkil C. The efficiency of various doses of topical isosorbide dinitrate in thetreatment of chronic anal fissure and the long-term results: A prospective,randomized and controlled clinical trial // Turk J Gastroenterol.
– 2012. – № 23(1). – P. 28 – 32.159. Krasnyuk I.I. (Jr.), Beliatskaya A.V., Krasnyuk I.I. et al. Effect of Soliddispersions on the dissolution of Ampicillin // BioNanoScience. – 2016. – V. 6.– P. 1 – 5.160. Labarre D. Vauthier. Christine Biomedical and Pharmaceutical Polymers //Labarre, Denis; Ponchel, Gilles France. – 2010. – 176 p.161. Levy G. Effect of dosage form on drug absorption.
A freguent variable inclinical pharmacology // Arch Int Pharmacodyn Ther. – 1964. – V. 152, № 1-2.– P. 59 – 68.162. Levy G. Effect of particle size on dissolution and gastrointestinal absorptionrates of pharmaceuticals // Am J Pharmacy. – 1963. – V. 135, № 3. – P. 78 –92.163. Messerli F.H., McLaughlin M. Cardiac effects of calcium antagonists inhypertension in: Epstein M, ed. Calcium antagonists in clinical medicine. //Hanley and Belfus. – 1992. – Р. 137 – 150.164. Mooter G. Van den.
Physico-chemical characterization of solid dispersionsof temazepam with polyethylene glycol 6000 and PVP K30 // Int. J. Pharm. –1998. – V. 164. – № 1-2. – P. 67 – 80.130165. Muller R.H., Runge S., Mehnert W. Oral bioavailability of cyclosporine:solid lipid nanoparticles vs. drug nanocristalls // Int. J. pharm. – 2006. – 317. –P.82 – 89.166. Myers M.G., Raemsch K.D. et al. Comparative pharmcokinetics andantihypertensive effects of the nifedipine tablet and capsule // J CardiovascPharmacol. – 1987.
– suppl. 10. – Р. 76 – 78.167. Nagar C. Dissolution Profilling of Nimesulide Solid Dispersions WithPolyethylene Glycol, Talc and Their Combinations As Dispersion Carriers. –2010. – V. 2, № 1. – P. 480 – 484.168. Newa M., Hari Bhandari K., Xun Lee D. et al. Enhanced dissolution ofIbuprofen using solid dispersion with polyethylene glycol 20000 // DrugDevelopment and Industrial Pharmacy. – 2008. – V.
34. – Р. 1013 – 1021.169. Okonog S. Dissolution improvement of high drug-loaded solid dispersion //AAPS PharmSciTech. – 2006. – V. 7, № 2. – P. 52.170. Perrotti P., Dominici P., Grossi E. et al. Topical nifedipine with lidocaineointment versus active control for pain after hemorrhoidectomy: results of amulticentre, prospective, randomized, double-blind study // Can J. Surg. – 2010.– № 53 (1). –Р.
17 – 24.171. Radomska-Soukharev A. Stability of lipid excipients in lipid solidnanoparticles. // Adv. Drug. Deliv. Rev. –2007. – 50. – P.411 – 418.172. Ramvallabh Zawar L., Baburao Bari S. Preparation, Characterization and inVivo Evaluation of Antihyperglycemic Activity of Microwave GeneratedRepaglinide Solid Dispersion // Him. Farm. Bull. – 2012.
